Home Cart 0 Sign in  
X

[ CAS No. 6089-04-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 6089-04-9
Chemical Structure| 6089-04-9
Chemical Structure| 6089-04-9
Structure of 6089-04-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 6089-04-9 ]

Related Doc. of [ 6089-04-9 ]

Alternatived Products of [ 6089-04-9 ]

Product Details of [ 6089-04-9 ]

CAS No. :6089-04-9 MDL No. :MFCD00006604
Formula : C8H12O2 Boiling Point : -
Linear Structure Formula :- InChI Key :HQAXHIGPGBPPFU-UHFFFAOYSA-N
M.W : 140.18 Pubchem ID :98609
Synonyms :

Calculated chemistry of [ 6089-04-9 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.75
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 38.79
TPSA : 18.46 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.41 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.26
Log Po/w (XLOGP3) : 1.05
Log Po/w (WLOGP) : 1.24
Log Po/w (MLOGP) : 1.16
Log Po/w (SILICOS-IT) : 1.83
Consensus Log Po/w : 1.51

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.24
Solubility : 8.09 mg/ml ; 0.0577 mol/l
Class : Very soluble
Log S (Ali) : -1.03
Solubility : 13.1 mg/ml ; 0.0937 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.98
Solubility : 14.7 mg/ml ; 0.105 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.6

Safety of [ 6089-04-9 ]

Signal Word:Danger Class:3
Precautionary Statements:P210-P403+P235 UN#:1993
Hazard Statements:H225 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 6089-04-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 6089-04-9 ]
  • Downstream synthetic route of [ 6089-04-9 ]

[ 6089-04-9 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 110-87-2 ]
  • [ 107-19-7 ]
  • [ 6089-04-9 ]
YieldReaction ConditionsOperation in experiment
97.2% With toluene-4-sulfonic acid In dichloromethane at 0 - 20℃; for 1 h; O-THP Propargyl alcohol (18) Compound 18 was prepared according to a literature procedure.24 To the solution of propargyl alcohol 17 (2.6mL, 44.6mmol) and p-TsOH monohydrate (0.09g, 0.5mmol) in CH2Cl2 (45mL) DHP (4.3mL, 46.8mmol) was added dropwise at 0°C. After stirring for 5min at 0°C, the reaction mixture was allowed to warm up to RT and was stirred for 1h. Next, the reaction mixture was washed with saturated NaHCO3 (30mL) and the aqueous layer was extracted with CH2Cl2 (45mL). The combined organic layer dried over MgSO4, filtered, and concentrated under reduced pressure to give compound 18 (6.1g, 97.2percent) as a yellow oil. Rf=0.30 (n-hexane/Et2O 95/5). 1H NMR (400MHz, CDCl3): δ=1.50–1.67 (m, 4H), 1.70–1.89 (m, 2H), 2.41 (t, J=2.4Hz, 1H), 3.52–3.57 (m, 1H), 3.82–3.87 (m, 1H), 4.27 (ddd, J=2.4Hz, 11.3Hz, 15.8Hz, 2H), 4.83 (t, J=3.4Hz, 1H). 13C NMR (100MHz, CDCl3): δ=19.0, 25.3, 30.2, 53.9, 61.9, 74.0, 79.7, 96.8. MS-CI: m/z calcd for C8H12O2 [M+H]+, 141; found, 141. This compound has been also previously reported.25
93% With toluene-4-sulfonic acid In dichloromethane at 0 - 20℃; Inert atmosphere TsOH (840 mg, 4.40 mmol) was added to dihydropyran (18.6 g, 0.220 mol) in dichloromethane (20 mL) at 0 ºC and stirred until it dissolved. Propargyl alcohol 15 (12.3 g, 0.220 mol) was added dropwise at 0 ºC. The reaction solution was warmed to rt and stirred overnight. The reaction was quenched with saturated NaHCO3, extracted with dichloromethane. The organic layer was washed with brine, dried with MgSO4 and concentrated to give 30.0 g brown liquid. The colorless liquid 16 was obtained from distillation at 40-41 ºC, 5 mmHg (21.5 g, 70 percent) and at 25 - 40 ºC, 6 mmHg (7.2g, 23 percent). 1H NMR (400 MHz, CDCl3): δ 1.54 (m, 2 H), 1.63 (m, 2 H), 1.74 (m, 1 H), 1.84 (m, 1 H), 2.40 (t, J = 2.4 Hz, 1 H), 3.53 (m, 1 H), 3.84 (m, 1 H), 4.23 (dd, J = 15.6, 2.4 Hz, 1 H), 4.30 (dd, J = 15.6, 2.4 Hz, 1 H), 4.82 (br t, J = 3.2 Hz, 1 H).
87% With toluene-4-sulfonic acid In dichloromethane at 29℃; for 2 h; To a solution of propargyl alcohol (1 g, 16.93 mmol) in dichloromethane (15 mL), PTSA (3 mg, 0.16 mmol) and DHP (3 mL, 33.86 mmol) were added and the reaction mixture was stirred at room temperature for 2 h. After completion of starting materials, the reaction mixture was quenched with NaHC03 and extracted with dichloromethane (100 mL x 2), washed with water (100 mL x 2), and brine (100 n L x 1). The combined organic extracts were evaporated under reduced pressure to obtain the crude product which was purified by column chromatography (100-200 mesh silica gel, eluent 10 percent EtOAc in hexane) to furnish compound (ii) (2.078 g, 87percent) as a light brown liquid.
82% at 25℃; for 3 h; To a solution of 15 g (0.18 mol) of dihydropyrane and 2 mg of p-toluenesulfonic acid was added 10 g (0.18 mol) of 2-propyn-1-ol. After stirring at 25 °C for 3 h, the reaction solution was diluted with 100 mL of diethyl ether and washed with 10percent aqueous NaHCO3, water, and brine, dried (MgSO4), concentrated to give 20.5 g (82percent yield) of 2-(2-propynyloxy)-tetrahydropyrane. 1H NMR δ 4.83 (t, J = 3.6 Hz, 1H, CHO), 4.29 (dd, J = 16, 3 Hz, 1H, CH2O), 4.26 (dd, J = 16, 3 Hz, 1H, CH2O), 3.88-3.82 (m, 1H, CHO), 3.58-3.52 (m, 1H, CHO), 2.42 (d, J = 3 Hz, 1H, CH), 1.90-1.50 (m, 6H); 13C NMR δ 97.0, 79.9, 74.2, 62.1, 54.1, 30.4, 25.5, 19.1; MS (electrospray; negative mode) m/z 139.0 (M - H-, 100percent). MS (electrospray; positive mode) m/z 163.1 (M + Na+; 100percent).
78% at 60℃; for 10 h; Sealed tube; Green chemistry General procedure: A mixture of corresponding alcohol (1, 1 mmol) and 3,4-dihydro-2H-pyran (2, 100 mg, 1.2 mmol) was stirred in the presence of zwitterionic-salt A (10 mg, 10 molpercent) at 60-80 °C (oil bath) for 10-12 h in a seal tube. After completion of the reaction (TLC), the reaction mixture was cooled to room temperature and diluted with water (10 mL) and extracted with ethyl acetate (20 mL). Organic layer was dried over anhydrous Na2SO4. After evaporation of solvent the crude product was purified by column chromatography on silica gel using petroleum ether/ethyl acetate (4-5percent) as eluent.

Reference: [1] Synlett, 2003, # 14, p. 2163 - 2166
[2] Tetrahedron, 2010, vol. 66, # 25, p. 4573 - 4576
[3] Synthesis, 2005, # 19, p. 3293 - 3296
[4] Journal of the Chinese Chemical Society, 2007, vol. 54, # 2, p. 525 - 532
[5] Journal of Organic Chemistry, 2009, vol. 74, # 4, p. 1531 - 1540
[6] Recueil des Travaux Chimiques des Pays-Bas, 1989, vol. 108, # 9, p. 304 - 313
[7] Gazzetta Chimica Italiana, 1980, vol. 110, # 9/10, p. 523 - 526
[8] Journal of the American Chemical Society, 1999, vol. 121, # 39, p. 9034 - 9042
[9] Tetrahedron Asymmetry, 2005, vol. 16, # 23, p. 3773 - 3784
[10] Synthesis, 2007, # 5, p. 779 - 790
[11] Journal of Molecular Catalysis A: Chemical, 2011, vol. 345, # 1-2, p. 96 - 100
[12] European Journal of Organic Chemistry, 2013, # 22, p. 4903 - 4908
[13] Tetrahedron, 1990, vol. 46, # 11, p. 4063 - 4082
[14] Organic Letters, 2011, vol. 13, # 21, p. 5924 - 5927
[15] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 18, p. 5008 - 5015
[16] Tetrahedron Letters, 2005, vol. 46, # 15, p. 2543 - 2545
[17] Organic Syntheses, 1999, vol. 76, p. 178 - 178
[18] Synthesis, 1993, # 11, p. 1069 - 1070
[19] Tetrahedron Letters, 1998, vol. 39, # 44, p. 8159 - 8162
[20] Tetrahedron, 2001, vol. 57, # 5, p. 889 - 898
[21] Synthetic Communications, 2002, vol. 32, # 10, p. 1549 - 1555
[22] Patent: US4186141, 1980, A,
[23] Journal of Labelled Compounds and Radiopharmaceuticals, 1994, vol. 34, # 8, p. 747 - 757
[24] Synthetic Communications, 2005, vol. 35, # 14, p. 1939 - 1945
[25] Journal of Organic Chemistry, 2001, vol. 66, # 22, p. 7511 - 7513
[26] European Journal of Organic Chemistry, 2013, # 29, p. 6710 - 6721
[27] Chemistry - A European Journal, 2015, vol. 21, # 4, p. 1482 - 1487
[28] Canadian Journal of Chemistry, 1987, vol. 65, p. 43 - 55
[29] Canadian Journal of Chemistry, 1987, vol. 65, p. 56 - 68
[30] Journal of Organic Chemistry, 1981, vol. 46, p. 5340 - 5343
[31] Journal of Organic Chemistry, 1985, vol. 50, # 24, p. 4762 - 4766
[32] Journal of Medicinal Chemistry, 1995, vol. 38, # 6, p. 875 - 882
[33] Journal of Chemical Research - Part S, 1996, # 11, p. 494 - 495
[34] Tetrahedron, 1999, vol. 55, # 17, p. 5449 - 5456
[35] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 7, p. 1811 - 1822
[36] Australian Journal of Chemistry, 1997, vol. 50, # 11, p. 1067 - 1079
[37] Synlett, 1999, # 8, p. 1261 - 1262
[38] Tetrahedron Letters, 2002, vol. 43, # 15, p. 2801 - 2805
[39] Tetrahedron Letters, 2006, vol. 47, # 14, p. 2341 - 2344
[40] Journal of the American Chemical Society, 2001, vol. 123, # 50, p. 12736 - 12737
[41] Journal of Organic Chemistry, 1983, vol. 48, # 13, p. 2151 - 2158
[42] Tetrahedron Letters, 1993, vol. 34, # 33, p. 5269 - 5272
[43] Organic Letters, 2017, vol. 19, # 19, p. 5340 - 5343
[44] Tetrahedron Letters, 1998, vol. 39, # 50, p. 9287 - 9288
[45] Australian Journal of Chemistry, 2002, vol. 55, # 12, p. 795 - 798
[46] Synthetic Communications, 2006, vol. 36, # 19, p. 2893 - 2900
[47] Organic Letters, 2008, vol. 10, # 6, p. 1075 - 1078
[48] Journal of Organic Chemistry, 2013, vol. 78, # 15, p. 7714 - 7726
[49] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1991, # 3, p. 581 - 587
[50] Organic Preparations and Procedures International, 1996, vol. 28, # 5, p. 613 - 617
[51] Synthetic Communications, 2000, vol. 30, # 23, p. 4323 - 4328
[52] Angewandte Chemie - International Edition, 2016, vol. 55, # 44, p. 13719 - 13723[53] Angew. Chem., 2016, vol. 128, p. 13923 - 13927,5
[54] European Journal of Organic Chemistry, 2014, vol. 2014, # 32, p. 7095 - 7098
[55] Patent: WO2013/71418, 2013, A1, . Location in patent: Page/Page column 19-20
[56] Bulletin of the Chemical Society of Japan, 1984, vol. 57, # 10, p. 2768 - 2776
[57] Journal of Organic Chemistry, 2004, vol. 69, # 21, p. 7157 - 7170
[58] Steroids, 1983, vol. 41, # 3, p. 339 - 348
[59] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1992, # 9, p. 1089 - 1100
[60] Chemistry - A European Journal, 2011, vol. 17, # 27, p. 7480 - 7491
[61] Synthetic Communications, 2013, vol. 43, # 9, p. 1237 - 1242
[62] Chemistry - A European Journal, 1998, vol. 4, # 11, p. 2342 - 2352
[63] Chemistry - A European Journal, 2003, vol. 9, # 11, p. 2419 - 2438
[64] New Journal of Chemistry, 2001, vol. 25, # 1, p. 40 - 54
[65] Canadian Journal of Chemistry, 2001, vol. 79, # 8, p. 1259 - 1271
[66] Angewandte Chemie - International Edition, 2017, vol. 56, # 3, p. 847 - 850[67] Angew. Chem., 2017, vol. 129, p. 865 - 868,4
[68] Advanced Synthesis and Catalysis, 2012, vol. 354, # 7, p. 1363 - 1372
[69] European Journal of Medicinal Chemistry, 2012, vol. 50, p. 311 - 318
[70] Tetrahedron, 1998, vol. 54, # 36, p. 10779 - 10788
[71] Journal of Organic Chemistry, 1998, vol. 63, # 18, p. 6128 - 6131
[72] European Journal of Organic Chemistry, 2001, # 13, p. 2577 - 2588
[73] Journal of the Chemical Society. Perkin Transactions 1, 2002, # 13, p. 1555 - 1563
[74] Synthetic Communications, 1996, vol. 26, # 24, p. 4539 - 4544
[75] Tetrahedron Letters, 2004, vol. 45, # 26, p. 5135 - 5138
[76] Synthetic Communications, 2017, vol. 47, # 20, p. 1905 - 1915
[77] European Journal of Organic Chemistry, 2014, vol. 2014, # 22, p. 4733 - 4740
[78] Natural Product Research, 2010, vol. 24, # 13, p. 1274 - 1281
[79] Bulletin of the Chemical Society of Japan, 1994, vol. 67, # 10, p. 2838 - 2849
[80] Bulletin of the Chemical Society of Japan, 1995, vol. 68, # 6, p. 1689 - 1705
[81] Journal of Photochemistry and Photobiology A: Chemistry, 2017, vol. 349, p. 162 - 170
[82] Synthetic Communications, 1989, vol. 19, # 5and6, p. 901 - 906
[83] Canadian Journal of Chemistry, 2006, vol. 84, # 9, p. 1174 - 1179
[84] Journal of the Chemical Society - Perkin Transactions 1, 1998, # 11, p. 1839 - 1858
[85] Journal of the American Chemical Society, 1953, vol. 75, p. 4048,4050
[86] Journal of the Chemical Society, 1950, p. 3646,3649
[87] Collection of Czechoslovak Chemical Communications, 1981, vol. 46, # 4, p. 917 - 925
[88] Journal of Organometallic Chemistry, 1987, vol. 319, p. 333 - 344
[89] Journal of Chemical Research, Miniprint, 1982, # 2, p. 321 - 351
[90] Journal of the American Chemical Society, 1994, vol. 116, # 26, p. 12093 - 12094
[91] Journal of the American Chemical Society, 1996, vol. 118, # 1, p. 275 - 276
[92] Tetrahedron: Asymmetry, 1997, vol. 8, # 20, p. 3393 - 3396
[93] Journal of Chemical Ecology, 1995, vol. 21, # 3, p. 299 - 311
[94] Synthetic Communications, 2003, vol. 33, # 22, p. 3929 - 3934
[95] Journal of Organic Chemistry, 2006, vol. 71, # 9, p. 3639 - 3642
[96] Journal of the American Chemical Society, 2006, vol. 128, # 9, p. 2772 - 2773
[97] Journal of Organic Chemistry, 2001, vol. 66, # 24, p. 8120 - 8126
[98] Journal of the Chemical Society. Perkin Transactions 1, 2002, # 22, p. 2485 - 2489
[99] Patent: US2003/3245, 2003, A1,
[100] Patent: US5238832, 1993, A,
[101] Patent: US5502073, 1996, A,
[102] Patent: US2003/220313, 2003, A1, . Location in patent: Page/Page column 5
[103] Patent: WO2004/46079, 2004, A1, . Location in patent: Page/Page column 14-16
  • 2
  • [ 110-87-2 ]
  • [ 104-15-4 ]
  • [ 6089-04-9 ]
Reference: [1] Patent: US4254285, 1981, A,
[2] Patent: US4477388, 1984, A,
[3] Patent: US4194055, 1980, A,
[4] Patent: US4170597, 1979, A,
[5] Patent: US4218566, 1980, A,
[6] Patent: US4233231, 1980, A,
[7] Patent: US4085272, 1978, A,
  • 3
  • [ 64244-47-9 ]
  • [ 6089-04-9 ]
Reference: [1] Tetrahedron Letters, 1999, vol. 40, # 18, p. 3655 - 3656
[2] Tetrahedron, 2000, vol. 56, # 47, p. 9365 - 9373
  • 4
  • [ 142-68-7 ]
  • [ 107-19-7 ]
  • [ 6089-04-9 ]
Reference: [1] Organic and Biomolecular Chemistry, 2015, vol. 13, # 12, p. 3787 - 3791
  • 5
  • [ 3174-74-1 ]
  • [ 107-19-7 ]
  • [ 6089-04-9 ]
Reference: [1] Journal of Organometallic Chemistry, 1987, vol. 328, # 1-2, p. 223 - 227
  • 6
  • [ 51926-85-3 ]
  • [ 6089-04-9 ]
Reference: [1] Synlett, 2010, # 20, p. 3073 - 3077
  • 7
  • [ 36551-06-1 ]
  • [ 6089-04-9 ]
Reference: [1] Phosphorus, Sulfur and Silicon and Related Elements, 2001, vol. 171-172, p. 167 - 172
  • 8
  • [ 199998-50-0 ]
  • [ 6089-04-9 ]
Reference: [1] Phosphorus, Sulfur and Silicon and Related Elements, 2001, vol. 171-172, p. 167 - 172
  • 9
  • [ 75-77-4 ]
  • [ 6089-04-9 ]
  • [ 5272-36-6 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1993, vol. 130, # 2, p. 154 - 159
  • 10
  • [ 75-77-4 ]
  • [ 6089-04-9 ]
  • [ 38002-45-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 1997, vol. 7, # 24, p. 3189 - 3194
Same Skeleton Products
Historical Records

Similar Product of
[ 6089-04-9 ]

Chemical Structure| 861954-02-1

A1267869[ 861954-02-1 ]

2-(2-Propynyloxy)tetrahydropyran-13C3

Reason: Stable Isotope

Related Functional Groups of
[ 6089-04-9 ]

Alkynes

Chemical Structure| 10160-87-9

[ 10160-87-9 ]

3,3-Diethoxyprop-1-yne

Similarity: 0.69

Ethers

Chemical Structure| 64001-06-5

[ 64001-06-5 ]

4-((Tetrahydrofuran-2-yl)oxy)butan-1-ol

Similarity: 0.73

Chemical Structure| 696-59-3

[ 696-59-3 ]

2,5-Dimethoxytetrahydrofuran

Similarity: 0.70

Chemical Structure| 33821-94-2

[ 33821-94-2 ]

2-(3-Bromopropoxy)tetrahydro-2H-pyran

Similarity: 0.70

Chemical Structure| 31608-22-7

[ 31608-22-7 ]

2-(4-Bromobutoxy)tetrahydro-2H-pyran

Similarity: 0.70

Chemical Structure| 17739-45-6

[ 17739-45-6 ]

2-(2-Bromoethoxy)tetrahydro-2H-pyran

Similarity: 0.70

Related Parent Nucleus of
[ 6089-04-9 ]

Aliphatic Heterocycles

Chemical Structure| 33821-94-2

[ 33821-94-2 ]

2-(3-Bromopropoxy)tetrahydro-2H-pyran

Similarity: 0.70

Chemical Structure| 31608-22-7

[ 31608-22-7 ]

2-(4-Bromobutoxy)tetrahydro-2H-pyran

Similarity: 0.70

Chemical Structure| 17739-45-6

[ 17739-45-6 ]

2-(2-Bromoethoxy)tetrahydro-2H-pyran

Similarity: 0.70

Chemical Structure| 64519-82-0

[ 64519-82-0 ]

(3R,4R,5R)-6-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,3,4,5-pentaol

Similarity: 0.66

Chemical Structure| 156928-09-5

[ 156928-09-5 ]

(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-ol

Similarity: 0.64

Tetrahydropyrans

Chemical Structure| 33821-94-2

[ 33821-94-2 ]

2-(3-Bromopropoxy)tetrahydro-2H-pyran

Similarity: 0.70

Chemical Structure| 31608-22-7

[ 31608-22-7 ]

2-(4-Bromobutoxy)tetrahydro-2H-pyran

Similarity: 0.70

Chemical Structure| 17739-45-6

[ 17739-45-6 ]

2-(2-Bromoethoxy)tetrahydro-2H-pyran

Similarity: 0.70

Chemical Structure| 64519-82-0

[ 64519-82-0 ]

(3R,4R,5R)-6-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,3,4,5-pentaol

Similarity: 0.66

Chemical Structure| 585-88-6

[ 585-88-6 ]

(2S,3R,4R,5R)-4-(((2R,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,3,5,6-pentaol

Similarity: 0.66